{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:47:51Z","timestamp":1791402471062,"version":"4.3.3"},"reference-count":35,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Diabetes mellitus type 2 is a risk factor for developing heart failure and myocardial fibrosis, but there is no specific therapy for diabetic heart disease. 1-[2-(4-methoxyphenyl)]-2-[3-(4-methoxyphenyl) propoxy]ethyl-1H-imidazole (SKF96365) is regarded as an inhibitor of receptor-mediated calcium ion (Ca2+) entry. This study aimed to explore the effects of SKF96365 on diabetic myocardial fibrosis. Methods: A type 2 diabetic rat model induced by a high-sugar and high-fat diet combined with streptozotocin was established. Thirty specific pathogen-free male Wistar rats were divided randomly into three groups: group A (the blank control group), group B (the diabetes group) and group C (the diabetes + transient receptor potential canonical channel [TRPC] blocker intervention group). Group C was given 0.74-\u00b5mol\/kg SKF96365 by intraperitoneal injection, and groups A and B were given the same amount of normal saline by intraperitoneal injection. The weight and blood sugar of the rats were monitored. After 12 weeks, the weight of the whole heart and the left ventricle was measured, and the heart and the left ventricular weight ratios were calculated. Haematoxylin\u2013eosin (HE) staining was used to observe pathological changes in the myocardial tissue and the distribution of nuclei. Masson staining was used to identify collagen and muscle fibres, and the myocardial collagen volume fraction (CVF) was calculated. Semi-quantitative reverse transcription\u2013polymerase chain reaction was used to detect the messenger ribonucleic acid (mRNA) expression of SKF96365 target genes. A value of p &lt; 0.05 indicated that the difference between the groups was statistically significant. Results: Compared with the weight of the rats in group A, the weight of those in groups B and C decreased, while blood sugar, whole heart weight and left ventricular weight increased (p &lt; 0.05). There was no significant difference in body weight between the rats in groups B and C (p &gt; 0.05). The HE staining results showed that the arrangement of cardiomyocytes in groups B and C was irregular, and focal necrosis was seen in severe cases. The degree of diabetic cardiomyopathy (DCM) in group C was less severe than that in group B. Masson staining showed that the CVF increased in groups B and C, with group B &gt; group C (p &lt; 0.05); the mRNA expressions of TRPC3 and TRPC6 were upregulated in groups A, B and C, and the mRNA expressions of TRPC3 and TRPC6 in group C were downregulated compared with those in group B (p &lt; 0.05). Compared with the expression levels of SKF96365 target genes (STIM1, Orai1 and Homer1) in group A, those in group B were lower, while the administration of SKF96365 in group C did not affect the expression levels of those genes. Conclusions: SKF96365 can effectively improve myocardial fibrosis in type-II diabetic rats.<\/jats:p>","DOI":"10.31083\/j.fbl2809231","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T09:04:54Z","timestamp":1695805494000},"source":"Crossref","is-referenced-by-count":4,"title":["Effect of SKF96365 on Myocardial Fibrosis in Type-II Diabetic Rats"],"prefix":"10.31083","volume":"28","author":[{"given":"Huan-zhi","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Emergency, The First Affiliated Hospital of China Medical University, 110001 Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Emergency, The First Affiliated Hospital of China Medical University, 110001 Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Yao X, Pei X, Yang Y, Zhang H, Xia M, Huang R, et al. Distribution of diabetic retinopathy in diabetes mellitus patients and its association rules with other eye diseases. Scientific Reports. 2021; 11: 16993.","DOI":"10.1038\/s41598-021-96438-w"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Wang J, Wang R, Li J, Yao Z. Rutin alleviates cardiomyocyte injury induced by high glucose through inhibiting apoptosis and endoplasmic reticulum stress. Experimental and Therapeutic Medicine. 2021; 22: 944.","DOI":"10.3892\/etm.2021.10376"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Zhu HZ, Zhang LY, Zhai ME, Xia L, Cao Y, Xu L, et al. GDF11 Alleviates Pathological Myocardial Remodeling in Diabetic Cardiomyopathy Through SIRT1-Dependent Regulation of Oxidative Stress and Apoptosis. Frontiers in Cell and Developmental Biology. 2021; 9: 686848.","DOI":"10.21203\/rs.3.rs-357210\/v1"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Yu Y, Zheng G. Troxerutin protects against diabetic cardiomyopathy through NF \u03baB\/AKT\/IRS1 in a rat model of type 2 diabetes. Molecular Medicine Reports. 2017; 15: 3473\u20133478.","DOI":"10.3892\/mmr.2017.6456"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Wang B, Xiong S, Lin S, Xia W, Li Q, Zhao Z, et al. Enhanced Mitochondrial Transient Receptor Potential Channel, Canonical Type 3-Mediated Calcium Handling in the Vasculature From Hypertensive Rats. Journal of the American Heart Association. 2017; 6: e005812.","DOI":"10.1161\/JAHA.117.005812"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Gao H, Wang F, Wang W, Makarewich CA, Zhang H, Kubo H, et al. Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling. Journal of Molecular and Cellular Cardiology. 2012; 53: 657\u2013667.","DOI":"10.1016\/j.yjmcc.2012.08.005"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Yue Z, Zhang Y, Xie J, Jiang J, Yue L. Transient receptor potential (TRP) channels and cardiac fibrosis. Current Topics in Medicinal Chemistry. 2013; 13: 270\u2013282.","DOI":"10.2174\/1568026611313030005"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Hu Q, Ahmad AA, Seidel T, Hunter C, Streiff M, Nikolova L, et al. Location and function of transient receptor potential canonical channel 1 in ventricular myocytes. Journal of Molecular and Cellular Cardiology. 2020; 139: 113\u2013123.","DOI":"10.1016\/j.yjmcc.2020.01.008"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, Hill JA, et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. Journal of Clinical Investigation. 2006; 116: 3114\u20133126.","DOI":"10.1172\/JCI27702"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Cheng H, Li J, Wu Q, Zheng X, Gao Y, Yang Q, et al. Effect of SKF 96365 on cardiomyocyte hypertrophy induced by angiotensin II. Molecular Medicine Reports. 2020; 21: 806\u2013814.","DOI":"10.3892\/mmr.2019.10877"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Krolik A, Diamandakis D, Zych A, Stafiej A, Salinska E. The involvement of TRP channels in memory formation and task retrieval in a passive avoidance task in one-day old chicks. Neurobiology of Learning and Memory. 2020; 171: 107209.","DOI":"10.1016\/j.nlm.2020.107209"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Lopez JR, Uryash A, Faury G, Est\u00e8ve E, Adams JA. Contribution of TRPC Channels to Intracellular Ca2 + Dyshomeostasis in Smooth Muscle From mdx Mice. Frontiers in Physiology. 2020; 11: 126.","DOI":"10.3389\/fphys.2020.00126"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Liu Z, Du Z, Li K, Han Y, Ren G, Yang Z. TRPC6-Mediated Ca2+ Entry Essential for the Regulation of Nano-ZnO Induced Autophagy in SH-SY5Y Cells. Neurochemical Research. 2020; 45: 1602\u20131613.","DOI":"10.1007\/s11064-020-03025-y"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Jain PP, Hosokawa S, Xiong M, Babicheva A, Zhao T, Rodriguez M, et al. Revisiting the mechanism of hypoxic pulmonary vasoconstriction using isolated perfused \/ ventilated mouse lung. Pulmonary Circulation. 2020; 10: 2045894020956592.","DOI":"10.1177\/2045894020956592"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism: Clinical and Experimental. 2000; 49: 1390\u20131394.","DOI":"10.1053\/meta.2000.17721"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Yang F, Qin Y, Wang Y, Meng S, Xian H, Che H, et al. Metformin Inhibits the NLRP3 Inflammasome via AMPK\/mTOR-dependent Effects in Diabetic Cardiomyopathy. International Journal of Biological Sciences. 2019; 15: 1010\u20131019.","DOI":"10.7150\/ijbs.29680"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Li C, Zhang J, Xue M, Li X, Han F, Liu X, et al. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovascular Diabetology. 2019; 18: 1\u201313.","DOI":"10.1186\/s12933-019-0816-2"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Meng K, Cai H, Cai S, Hong Y, Zhang X. Adiponectin Modified BMSCs Alleviate Heart Fibrosis via Inhibition TGF-beta1\/Smad in Diabetic Rats. Frontiers in Cell and Developmental Biology. 2021; 9: 644160.","DOI":"10.3389\/fcell.2021.644160"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Luo B, Li B, Wang W, Liu X, Xia Y, Zhang C, et al. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS ONE. 2014; 9: e104771.","DOI":"10.1371\/journal.pone.0104771"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ji R, Chou CL, Xu W, Chen XB, Woodward DF, Regan JW. EP1 prostanoid receptor coupling to G i\/o up-regulates the expression of hypoxia-inducible factor-1 alpha through activation of a phosphoinositide-3 kinase signaling pathway. Molecular Pharmacology. 2010; 77: 1025\u20131036.","DOI":"10.1124\/mol.110.063933"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Bilim O, Takeishi Y, Kitahara T, Arimoto T, Niizeki T, Sasaki T, et al. Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus. Cardiovascular Diabetology. 2008; 7: 2.","DOI":"10.1186\/1475-2840-7-2"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Zhang H, Chen X, Zong B, Yuan H, Wang Z, Wei Y, et al. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation. Journal of Cellular and Molecular Medicine. 2018; 22: 4437\u20134448.","DOI":"10.1111\/jcmm.13743"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Miyazawa M, Yasuda M, Fujita M, Hirabayashi K, Hirasawa T, Kajiwara H, et al. Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway. The Journal of Obstetrics and Gynaecology Research. 2010; 36: 448\u2013453.","DOI":"10.1111\/j.1447-0756.2009.01127.x"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Lin R, Bao X, Wang H, Zhu S, Liu Z, Chen Q, et al. TRPM2 promotes pancreatic cancer by PKC\/MAPK pathway. Cell Death & Disease. 2021; 12: 585.","DOI":"10.1038\/s41419-021-03856-9"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Lee K, Jo YY, Chung G, Jung JH, Kim YH, Park CK. Functional Importance of Transient Receptor Potential (TRP) Channels in Neurological Disorders. Frontiers in Cell and Developmental Biology. 2021; 9: 611773.","DOI":"10.3389\/fcell.2021.611773"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Amato A, Terzo S, Lentini L, Marchesa P, Mul\u00e8 F. TRPM8 Channel Activation Reduces the Spontaneous Contractions in Human Distal Colon. International Journal of Molecular Sciences. 2020; 21: 5403.","DOI":"10.3390\/ijms21155403"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Arvanitis DA, Vafiadaki E, Sanoudou D, Kranias EG. Histidine-rich calcium binding protein: the new regulator of sarcoplasmic reticulum calcium cycling. Journal of Molecular and Cellular Cardiology. 2011; 50: 43\u201349.","DOI":"10.1016\/j.yjmcc.2010.08.021"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Tang SG, Liu XY, Wang SP, Wang HH, Jovanovi\u0107 A, Tan W. Trimetazidine prevents diabetic cardiomyopathy by inhibiting Nox2\/TRPC3-induced oxidative stress. Journal of Pharmacological Sciences. 2019; 139: 311\u2013318.","DOI":"10.1016\/j.jphs.2019.01.016"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Oda S, Numaga-Tomita T, Kitajima N, Toyama T, Harada E, Shimauchi T, et al. TRPC6 counteracts TRPC3-Nox2 protein complex leading to attenuation of hyperglycemia-induced heart failure in mice. Scientific Reports. 2017; 7: 7511.","DOI":"10.1038\/s41598-017-07903-4"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Liu D, Zhu Z, Tepel M. The role of transient receptor potential channels in metabolic syndrome. Hypertension Research. 2008; 31: 1989\u20131995.","DOI":"10.1291\/hypres.31.1989"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Amasaki Y. Calcineurin inhibitors and calcineurin-NFAT system. Nihon Rinsho Meneki Gakkai Kaishi. 2010; 33: 249\u2013261. (In Janpanese)","DOI":"10.2177\/jsci.33.249"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Horiba M, Muto T, Ueda N, Opthof T, Miwa K, Hojo M, et al. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers. Life Sciences. 2008; 82: 554\u2013560.","DOI":"10.1016\/j.lfs.2007.11.010"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Wuensch T, Thilo F, Krueger K, Scholze A, Ristow M, Tepel M. High glucose-induced oxidative stress increases transient receptor potential channel expression in human monocytes. Diabetes. 2010; 59: 844\u2013849.","DOI":"10.2337\/db09-1100"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Tian J, Zhang M, Suo M, Liu D, Wang X, Liu M, et al. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPK\u03b1\/TGF-\u03b2\/Smad signalling in type 2 diabetic rats. Journal of Cellular and Molecular Medicine. 2021; 25: 7642\u20137659.","DOI":"10.1111\/jcmm.16601"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Singh A, Hildebrand ME, Garcia E, Snutch TP. The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels. British Journal of Pharmacology. 2010; 160: 1464\u20131475.","DOI":"10.1111\/j.1476-5381.2010.00786.x"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/28\/9\/10.31083\/j.fbl2809231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T13:03:41Z","timestamp":1732712621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/28\/9\/10.31083\/j.fbl2809231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2768-6701(23)00806-7"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2809231","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"article-number":"231"}}